# HPV Integration Testing for Human Papillomavirus-Positive Women

> **NCT02576262** · — · UNKNOWN · sponsor: **Huazhong University of Science and Technology** · enrollment: 1200 (estimated)

## Conditions studied

- Cervical Intraepithelial Neoplasia
- Cervical Cancer

## Interventions

- **PROCEDURE:** TCT，HPV，colposcopic inspection

## Key facts

- **NCT ID:** NCT02576262
- **Lead sponsor:** Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2018-09
- **Final completion:** 2020-09
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2017-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02576262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02576262, "HPV Integration Testing for Human Papillomavirus-Positive Women". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02576262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*